AU2804297A - Method of and composition for treating disorders of the skin using vitamin k - Google Patents
Method of and composition for treating disorders of the skin using vitamin kInfo
- Publication number
- AU2804297A AU2804297A AU28042/97A AU2804297A AU2804297A AU 2804297 A AU2804297 A AU 2804297A AU 28042/97 A AU28042/97 A AU 28042/97A AU 2804297 A AU2804297 A AU 2804297A AU 2804297 A AU2804297 A AU 2804297A
- Authority
- AU
- Australia
- Prior art keywords
- vitamin
- skin
- composition
- treating disorders
- disorders
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63606796A | 1996-04-22 | 1996-04-22 | |
US08636067 | 1996-04-22 | ||
PCT/US1997/006464 WO1997039746A1 (en) | 1996-04-22 | 1997-04-22 | Method of and composition for treating disorders of the skin using vitamin k |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2804297A true AU2804297A (en) | 1997-11-12 |
Family
ID=24550287
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU28042/97A Abandoned AU2804297A (en) | 1996-04-22 | 1997-04-22 | Method of and composition for treating disorders of the skin using vitamin k |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2804297A (en) |
WO (1) | WO1997039746A1 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
CA2329160A1 (en) * | 1998-06-11 | 1999-12-16 | University Of Medicine & Dentistry Of New Jersey | Wound treatment through inhibition of adenosine diphosphate ribosyl transferase |
KR100355952B1 (en) * | 2000-03-15 | 2002-10-11 | 주식회사 코리아나화장품 | Skin Care Composition Containing Fish Cartilage Extract and Polypeptide Phytonadione |
JP2004532853A (en) | 2001-05-09 | 2004-10-28 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | Use of the composition for the purpose of treating rosacea |
US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
US7365167B2 (en) | 2001-11-26 | 2008-04-29 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
US7390885B2 (en) | 2001-11-26 | 2008-06-24 | Cell Matrix, Inc. | Humanized collagen antibodies and related methods |
PT1594456E (en) | 2003-01-20 | 2008-12-16 | Auriga Internat S A | Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
EP1442738A1 (en) * | 2003-01-28 | 2004-08-04 | Auriga International S.A. | Dermatological cosmetic composition comprising vitamin K1 oxide |
KR101143719B1 (en) * | 2003-05-27 | 2012-05-09 | 디에스엠 아이피 어셋츠 비.브이. | Novel nutraceutical compositions and use thereof |
CA2851079A1 (en) | 2005-04-15 | 2006-10-26 | Albert Einstein College Of Medicine Of Yeshiva University | Vitamin k for prevention and treatment of skin rash secondary to anti-egfr therapy |
CA2656613A1 (en) | 2006-07-03 | 2008-01-10 | Genmab A/S | Prevention of rash in patients undergoing anti-egfr therapy |
CA2694318A1 (en) * | 2007-07-24 | 2009-05-22 | Viridis Biopharma Pvt Ltd. | Treatment of human disease conditions and disorders using vitamin k analogues and derivatives |
US9616127B2 (en) * | 2008-03-11 | 2017-04-11 | Livionex Inc. | Method and topical formulation for treating localized edema |
US8815953B2 (en) | 2008-03-13 | 2014-08-26 | Spectrum Pharmaceuticals, Inc. | Formulations of vitamin K analogs for topical use |
CN102781258A (en) | 2009-09-14 | 2012-11-14 | 雀巢产品技术援助有限公司 | Nutritional compositions for modulating inflammation including exogenous vitamin K2 |
WO2023119230A1 (en) | 2021-12-22 | 2023-06-29 | L'oreal | Coagulation pathway and nicotinamide-adenine dinucleotide pathway modulating compositions and methods of their use |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1339029C (en) * | 1988-06-20 | 1997-04-01 | Hiroyuki Kakoki | Transparent composition |
US5510391A (en) * | 1993-10-22 | 1996-04-23 | Mayapple Holdings, Llc | Method of treating blood vessel disorders of the skin using vitamin K |
-
1997
- 1997-04-22 AU AU28042/97A patent/AU2804297A/en not_active Abandoned
- 1997-04-22 WO PCT/US1997/006464 patent/WO1997039746A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997039746A1 (en) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4880197A (en) | Method for treatment of dermatological disorders | |
AU8089494A (en) | Composition and method for treating blood vessel disorders of the skin using vitamin | |
AU6974996A (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
AU6872498A (en) | Method and composition for skin treatment | |
AUPM672594A0 (en) | A method for the prophylaxis and/or treatment of proliferative and/or inflammatory skin disorders | |
AU4216089A (en) | Method and composition for treating and preventing dry skin disorders | |
AU3512295A (en) | Composition and method for treating hair | |
AU5439996A (en) | Compositions and methods for treating pain | |
AU2804297A (en) | Method of and composition for treating disorders of the skin using vitamin k | |
AU3497097A (en) | Improved method for treatment and diagnosis of il-5 mediated disorders | |
AU2836499A (en) | Cosmetic method of treating skin | |
AU5774699A (en) | Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders | |
AU1438295A (en) | Method for treatment of papulo-pustules and comedones of the skin | |
AU1714697A (en) | Method and composition for the treatment of osteoarthritis | |
AU3768795A (en) | Method and compositions for hair treatment | |
AU2251897A (en) | Method of treating liver disorders | |
AU5198898A (en) | Method for treatment of glutamate related disorders | |
AU3127795A (en) | Composition and treatment for baldness | |
AU2786197A (en) | Cosmetic method for treating and preventing the signs of skin ageing | |
AU6165898A (en) | Method and apparatus for the treatment of strabismus | |
AUPN104895A0 (en) | Methods of and preparations for the treatment of ailments and disorders | |
AU1593697A (en) | Composition for treating skin affections and process for its preparation | |
AU4027097A (en) | Method of treatment | |
AU1282099A (en) | Method for treatment of disorders of attention | |
AU4717399A (en) | Method of treatment for dermatological disorders and compositions therefor |